US 11939383
B7-H4 antibodies and methods and use thereof
granted A61PA61P37/00
Quick answer
US patent 11939383 (B7-H4 antibodies and methods and use thereof) held by Five Prime Therapeutics, Inc. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Five Prime Therapeutics, Inc.
- Grant date
- Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P37/00